With Ottobock SE & Co. KGaA, a new German stock is included in the global market from 9 October 2025. Founded in 1919, the internationally active family-owned company headquartered in Duderstadt, Lower Saxony, specialises in medical technology. According to its own information, Ottobock develops innovative products such as prostheses, orthoses, wheelchairs and exoskeletons and is the global technology leader in the field of wearable human bionics, which enhance or replace parts of the human body. The IPO of the company takes place in Frankfurt today. Immediately after the first pricing at Deutsche Börse, the new stock (ISIN: DE000BCK2223) will also be continuously tradable on the Vienna Stock Exchange’s international market segment.
The global market offers domestic investors a broad selection of around 900 international shares from 28 countries. Austrian investors can trade on their national stock exchange at domestic fees and during local trading hours. As market maker Lang & Schwarz ensures additional liquidity and attractive prices.